Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Onyx Sciences is an early-stage life sciences studio founded to validate and commercialize patent-protected biotech and medtech innovations. Located at the intersection of research and commercialization, they focus on transforming the understanding, diagnosis, and treatment of human diseases. The firm specializes in guiding biomedical innovations through critical stages, from feasibility to manufacturing readiness.
Onyx Sciences invests in early-stage interventions that target diseases with significant morbidity, mortality, or quality-of-life impact. Their investment areas include therapeutics, devices, and diagnostics, with a commitment to guiding innovations through regulatory strategy and clinical validation. Check sizes and specific funding amounts are not disclosed.
Onyx Sciences typically leads investment rounds in their focus areas, particularly in early-stage biotech and healthcare innovations.
The firm is open to follow-on investments, especially for companies that demonstrate significant progress in their development and commercialization efforts.
Specific details about the size of Onyx Sciences' current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.